A narrative review published in Cureus searched PubMed, Embase, and Scopus through August 2025, examining the intersection of GLP-1 therapy and autoimmune thyroid disease
Cumulative weight loss often reaches 20 to 35 pounds by the end of month 4, though this varies based on starting weight and adherence
Pregnancy and breastfeeding Insufficient research exists on copper peptide safety during pregnancy and breastfeeding
Some women prefer injecting Friday evening, allowing the peak side effect window (24-72 hours post-injection) to occur over the weekend when they can rest if needed
Neuropsychopharmacology 42, 23872397
IGF-1 LR3 has greater free tissue exposure for equivalent molar doses due to reduced binding-protein affinity, which amplifies that theoretical risk